Costa Rica vs Guinea-Bissau: Prevalence rate of hypertension in men aged 30-79
Costa Rica
36
in 2019
Guinea-Bissau
36
in 2019
Costa Rica rank
111th
Guinea-Bissau rank
111th
Prevalence rate of hypertension in men aged 30-79 over time
- Costa Rica
- Guinea-Bissau
How they compare
Costa Rica currently reports 36 against 36 in Guinea-Bissau, a difference of 0.
Across all 30 years both countries report, Guinea-Bissau has been ahead every year.
Costa Rica ranks 111th and Guinea-Bissau ranks 111th of 195 countries.
Guinea-Bissau has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Costa Rica | Guinea-Bissau | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 33.15 | 37.37 | 4.22 | Guinea-Bissau |
| 2000s | 35.82 | 38.7 | 2.88 | Guinea-Bissau |
| 2010s | 36.38 | 37.38 | 1 | Guinea-Bissau |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in men aged 30-79, Costa Rica or Guinea-Bissau?
- Costa Rica, at 36 against 36 in Guinea-Bissau as of 2019.
- What is the difference in prevalence rate of hypertension in men aged 30-79 between Costa Rica and Guinea-Bissau?
- 0, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Guinea-Bissau?
- 30 years are reported by both, from 1990 to 2019.
- How do Costa Rica and Guinea-Bissau rank globally for prevalence rate of hypertension in men aged 30-79?
- Costa Rica ranks 111th and Guinea-Bissau ranks 111th of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in men aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of male population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.